Announce Date | 05/22/2025 |
EPS Normalized Actual | $11.65 (Beat by $0.72) |
EPS GAAP Actual | $11.65 (Beat by $0.72) |
Revenue Actual | $7.754B |
Revenue Surprise | Beat by $7754M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.29706 |
EPS GAAP Estimate | $2.29706 |
Revenue Estimate | $3.50577707B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2028 | 28.63752 | 27.5 | 28.32411 | 29.35875 | 8 |
Jul 2027 | 26 | 30.29 | 25.58912 | 26.68574 | 11 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 10.09 | -0.83531 | 7.754B | 13.12% | 432.17M |
FQ1 2025 (Jan 2025) | 1.68 | 1.68 | 3.963B | 14.56% | 3963M |
FQ4 2024 (Oct 2024) | 0.7 | 0.7 | 3.283B | 9.29% | 3283M |
FQ3 2024 (Jul 2024) | -0.0714 | -0.0714 | 3.184B | 14.82% | 3184M |
FQ2 2024 (Apr 2024) | 8.53 | 8.53 | 6.737B | 10.67% | 6737M |
FQ1 2024 (Jan 2024) | 1.26 | 1.26 | 3.386B | 10.19% | 3386M |
FQ4 2023 (Oct 2023) | 0.86 | 0.86 | 2.978B | 100% | 2978M |
FQ3 2023 (Jul 2023) | 0.32 | 0.32 | 2.712B | 100% | 2712M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
2.29706
Consensus Revenue Estimates
3.50577707B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 3.48394 | -- | 3.47125 | 3.51491 | 10 |
FQ2 2027 (Apr 2027) | 13.33558 | -- | 13.287 | 13.45413 | 10 |
FQ1 2027 (Jan 2027) | 4.35582 | -- | 3.95975 | 4.41342 | 14 |
FQ4 2026 (Oct 2026) | 3.40712 | -- | 3.39471 | 3.43741 | 10 |
FQ3 2026 (Jul 2026) | 2.53138 | -- | 2.51232 | 2.57564 | 6 |
FQ2 2026 (Apr 2026) | 12.14841 | 16.94 | 12.05695 | 12.3608 | 6 |
FQ1 2026 (Jan 2026) | 3.08401 | 45.53 | 3.03166 | 3.16019 | 9 |
FQ4 2025 (Oct 2025) | 3.00265 | 76.69 | 2.98004 | 3.05514 | 10 |
FQ3 2025 (Jul 2025) | 2.29706 | 103.11 | 2.27977 | 2.33722 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 4.63B | -- | 4.62B | 4.66B | 18 |
FQ2 2027 (Apr 2027) | 9.06B | -- | 9.03B | 9.12B | 11 |
FQ1 2027 (Jan 2027) | 4.99B | -- | 4.64B | 5.04B | 18 |
FQ4 2026 (Oct 2026) | 4.21B | -- | 4.2B | 4.24B | 20 |
FQ3 2026 (Jul 2026) | 3.9B | -- | 3.88B | 3.95B | 7 |
FQ2 2026 (Apr 2026) | 8.03B | 3.42 | 7.98B | 8.14B | 8 |
FQ1 2026 (Jan 2026) | 4.26B | 7.06 | 4.21B | 4.35B | 4 |
FQ4 2025 (Oct 2025) | 3.78B | 13.07 | 3.75B | 3.83B | 6 |
FQ3 2025 (Jul 2025) | 3.51B | 9.18 | 3.49B | 3.55B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 10.92531 | 10.09 | -0.83531 | -8.28% |
FQ1 2025 (Jan 2025) | 1.68 | 1.68 | 100% | |
FQ4 2024 (Oct 2024) | 0.7 | 0.7 | 100% | |
FQ3 2024 (Jul 2024) | -0.0714 | -0.0714 | 100% | |
FQ2 2024 (Apr 2024) | 8.53 | 8.53 | 100% | |
FQ1 2024 (Jan 2024) | 1.26 | 1.26 | 100% | |
FQ4 2023 (Oct 2023) | 0.86 | 0.86 | 100% | |
FQ3 2023 (Jul 2023) | 0.32 | 0.32 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $7.32B | $7.75B | $432.17M | 5.57% |
FQ1 2025 (Jan 2025) | $0B | $3.96B | $3963M | 100% |
FQ4 2024 (Oct 2024) | $0B | $3.28B | $3283M | 100% |
FQ3 2024 (Jul 2024) | $0B | $3.18B | $3184M | 100% |
FQ2 2024 (Apr 2024) | $0B | $6.74B | $6737M | 100% |
FQ1 2024 (Jan 2024) | $0B | $3.39B | $3386M | 100% |
FQ4 2023 (Oct 2023) | $0B | $2.98B | $2978M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.71B | $2712M | 100% |